Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Steatohepatitis

Known as: Visceral Steatosis, Steatohepatitides, Fatty liver 
Inflammation of the liver related to lipid accumulation in fatty liver.
National Institutes of Health

Related topics

Related topics

20 relations
3-Hydroxyacyl-CoA Dehydrogenase DeficiencyANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROMEAdult-onset citrullinemia type 2Alstrom Syndrome
Expand

Broader (1)

Fatty Liver

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Genetics and epigenetics of NAFLD and NASH: Clinical impact.
Non-alcoholic fatty liver disease (NAFLD) is now recognised as the most common liver disease worldwide. It encompasses a broad… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2018
Review
2018
Chlorogenic acid (CGA): A pharmacological review and call for further research.
Phenolic acids have recently gained substantial attention due to their various practical, biological and pharmacological effects… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2018
Review
2018
Preclinical models of non-alcoholic fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) can manifest as non-alcoholic fatty liver (NAFL) or non-alcoholic steatohepatitis (NASH… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2018
Review
2018
Role of inflammatory response in liver diseases: Therapeutic strategies
Inflammation and tumorigenesis are tightly linked pathways impacting cancer development. Inflammasomes are key signalling… Expand
  • figure 1
Is this relevant?
Review
2017
Review
2017
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Increased fructose consumption has been suggested to contribute to non-alcoholic fatty liver disease (NAFLD), dyslipidemia, and… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
Non-alcoholic fatty liver disease (NAFLD) is a continuous spectrum of diseases characterized by excessive lipid accumulation in… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2017
Review
2017
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD). Quantitative risk of… Expand
  • table 2
  • table 3
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
The human gastrointestinal tract is colonised by a complex ecosystem of microorganisms. Intestinal bacteria are not only… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 3
Is this relevant?
Review
2017
Review
2017
Role of microRNAs in obesity and obesity-related diseases
In recent years, the link between regulatory microRNAs (miRNAs) and diseases has been the object of intensive research. miRNAs… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation.
Diabetes mellitus is a non-communicable disease that occurs in both developed and developing countries. This metabolic disease… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE